返回 Agenda
[V5-S3] How to Provide Drug Information from a Standpoint of a Patient (Part 2)
Session Chair(s)
Yuko Kojima, RPh
Sr. Executive Director
Eli Lilly Japan K.K., Japan
Mamoru Narukawa, PhD, RPh
Professor
Kitasato University, Japan
Determining what information patients and medical experts need, and how to make the information available to ensure proper drug use, is an essential issue. We will discuss various medical communication tools created by the pharmaceutical industry to encourage appropriate drug use (i.e., for medical experts, package inserts, interview forms, and guides for appropriate use; for patients, drug guides, and drug information sheets).
Speaker(s)
Tomoko Tanita
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Risk Communication Promotion Division, Office of Safety I
Junichi Nishino, MSc, RPh
Otsuka Pharmaceutical Co., Ltd., Japan
Head, Regulatory Affairs Department
Masahiro Hayashi, PhD
Toranomon Hospital, Japan
Pharmaceutical affairs specialist, Department of Pharmacy